Operator of a med tech company intended to address the largely unmet testing needs of patients presenting a broad range of conditions, such as cardiovascular and cerebrovascular diseases. The company manufactures medical equipment to assess hemostasis disorders. The company is engaged in the research and experimental development on natural sciences. The company s specializes in the development and commercialization of in vitro diagnostic tests for hemostasis abnormalities that cause hemorrhagic or thromboembolic manifestations. It offers user-friendly assays, Emo-tests aim to inform physician medical decision with respect to bleeding or clotting events in a broad range of clinical settings, encompassing neurovascular diseases, cancer, pregnancy, and pharmacological and non-pharmacological therapy management.